{
event: "article_read",
name: `Understanding 6‑Month CDP in MS: An Overview with Dr. Barry Singer`,
author: ``,
tags: `Multiple Sclerosis`,
publication_date: ``,
interaction_type: "content"
}
Understanding 6‑Month CDP in MS: An Overview with Dr. Barry Singer
A simplified walkthrough of how 6‑month Confirmed Disability Progression (CDP) is measured in MS clinical trials. Dr. Barry Singer explains how EDSS changes are assessed, why sustained progression matters, and how this endpoint helps distinguish real, lasting disability worsening from temporary fluctuations.
Related articles
MAT-BH-2600164/v1/March2026